SOURCE: AFI
A collaborative effort between researchers from the Indian Institute of Technology Madras (IIT Madras) and NASA’s Jet Propulsion Laboratory (JPL) is tackling a critical issue: the presence of multidrug-resistant pathogens on the International Space Station (ISS).
This research delves into the microbial landscape aboard the ISS, specifically focusing on how these microorganisms might impact astronaut health. The ultimate goal is to not only safeguard the well-being of space travelers but also translate these findings into solutions for healthcare challenges here on Earth.
By studying the behavior and adaptation of these pathogens in the unique microgravity environment of the ISS, researchers hope to gain valuable insights. This knowledge could be instrumental in developing new strategies to combat multidrug-resistant bacteria in hospitals and other healthcare settings where such pathogens pose a significant threat.
This collaborative research exemplifies the power of international cooperation in scientific exploration. By combining expertise from India and the United States, researchers are making strides towards a healthier future for both space travelers and people on Earth.